Concepedia

Marta Llauradó Fernández

ML

9

Publications

361

Citations

9

H-Index

2016

Active since

Affiliations

University of British Columbia(Current)

BC Cancer Agency

Centre Hospitalier de l’Université de Montréal

University of Calgary

Western University

Marta Llauradó Fernández is an author at University of British Columbia specializing in pathology, medicine, and oncology.

ORCID

Top concepts

Publications per year

2016–2023

9

Publications

9

Genomic analysis of low‐grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities

Dane Cheasley, Abhimanyu Nigam, Magnus Zethoven et al. · The Journal of Pathology · 2020 · 111 citations

, , +13

Differences in MEK inhibitor efficacy in molecularly characterized low-grade serous ovarian cancer cell lines.

Marta Llauradó Fernández, Gabriel E. DiMattia, Amy Dawson et al. · PubMed · 2016 · 45 citations · Full text

Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target

Marta Llauradó Fernández, Amy Dawson, Joshua Hoenisch et al. · Cancer Cell International · 2019 · 44 citations · Full text

Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma

Marta Llauradó Fernández, Amy Dawson, Hannah Kim et al. · Gynecologic Oncology · 2020 · 42 citations

, , +8

Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability

Raunak Shrestha, Marta Llauradó Fernández, Amy Dawson et al. · Cancer Research · 2021 · 38 citations · Full text

Rows per page

1–5 of 9